Inmune Bio, Inc. - 8-K Filing
Inmune Bio announces $4.5 million registered direct offering and private placement of common stock and warrants. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 7.01 Regulation FD Disclosure On October 28, 2026, the Company issued a press release announcing the pricing of the Offering, 9.01 Financial statements and Exhibits (d) Exhibits)
Tickers: $INMB